Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Muscle Fiber Fragment Treatment for Urinary Incontinence [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is testing a muscle fiber fragment-based treatment for urinary incontinence in Phase 1/2 and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Muscle Fiber Fragment Treatment

Snippet

Sponsor: Wake Forest University | Conditions: Urinary Incontinence | Phase 1, Phase 2 | Status: RECRUITING